🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

CHART Study of Coronary CT Angiography in Coronary Artery Disease

Recruitingn/aAges 18 Years - anyAllShanghai Zhongshan Hospital
NCT05380622 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In a cohort of patients referred to coronary computed tomography angiography (CCTA), the investigators aim: 1. To describe the natural history of the coronary atherosclerotic plaque development and progression or regression, as well as the plaque characterization and phenotypes over time by CCTA among deferred coronary lesions 2. To explore the precursors of plaques leading to acute coronary syndrome (ACS) or chronic coronary syndrome (CCS) in deferred coronary lesions 3. To investigate prognostic implication of qualitative and quantitative plaque analysis of stenosis and plaque features, disease patterns, hemodynamic parameters, and fat metrics on CCTA along with physiologic assessment 4. To investigate the effects of different treatment strategies according to stenosis and plaque features, fat metrics on CCTA along with physiologic assessments.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with an indication for CCTA. * Qualified patients who have signed a written informed consent form. Exclusion Criteria: * Left ventricular ejection fraction \< 35% * Acute ST-elevation myocardial infarction within 72 hours or previous coronary artery bypass graft surgery * Abnormal epicardial coronary flow (TIMI flow \< 3) * Planned coronary artery bypass graft surgery after diagnostic angiography * Poor quality of CCTA or other reasons by core lab that are unsuitable for plaque, physiological or fat analysis * Patients with a stent in the target vessel
💊

What it tests

  • Coronary CT angiography
📍

Where

1 site
Shanghai Zhongshan Hospital
Shanghai, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy